ANNEX I
a Further details on identity and specification of active substance are provided in the renewal report. | |||||
Common Name, Identification Numbers | IUPAC Name | Puritya | Date of approval | Expiration of approval | Specific provisions |
---|---|---|---|---|---|
Laminarin CAS No 9008-22-4 CIPAC No 671 | (1→3)-β-D-glucan (according to IUPAC-IUB Joint Commission on Biochemical Nomenclature) | ≥ 860 g/kg on dry matter (TC) | 1 March 2018 | 28 February 2033 | For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account. Conditions of use shall include risk mitigation measures, where appropriate. |
ANNEX II
The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in Part A, the entry 95 on laminarin is deleted;
in Part D, the following entry is added:
a Further details on identity and specification of active substance are provided in the renewal report. | ||||||
Number | Common Name, Identification Numbers | IUPAC Name | Puritya | Date of approval | Expiration of approval | Specific provisions |
---|---|---|---|---|---|---|
‘12 | Laminarin CAS No 9008-22-4 CIPAC No 671 | (1→3)-β-D-glucan (according to IUPAC-IUB Joint Commission on Biochemical Nomenclature) | ≥ 860 g/kg on dry matter (TC) | 1 March 2018 | 28 February 2033 | For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account. Conditions of use shall include risk mitigation measures, where appropriate.’ |